Results for tag: "Romidepsin"

Romidepsin is a drug used to treat cutaneous and peripheral T-cell lymphomas, a type of non-Hodgkin's lymphoma. It is a histone deacetylase inhibitor, meaning it works by blocking the activity of an enzyme that helps cancer cells grow and divide. It is administered intravenously and is approved for use in the United States, Europe, and other countries. Romidepsin is used in combination with other drugs to treat cutaneous T-cell lymphoma, including chemotherapy and radiation therapy. It is also used to treat peripheral T-cell lymphoma, a rare form of non-Hodgkin's lymphoma. Romidepsin is marketed by Celgene Corporation, a biopharmaceutical company based in the United States. Other companies involved in the market include Novartis, Merck, and Pfizer. Show Less Read more